WDNA WISDOMTREE BIOREVOLUTION FUND
- 16.311
- -0.342-2.05%
Cantor Fitzgerald Reiterates Overweight on Eli Lilly, Maintains $885 Price Target
Moderna Was Most Shorted S&P 500 Healthcare Stock in August for Second Consecutive Month
Natera Shares Are Trading Higher After the Company Announced the Publication of Three Peer-reviewed Papers, Resulting in Over 85 Peer-reviewed Publications on Its Cancer Diagnostic Test Signatera
Coeur Mining, Medical Properties Trust And RH Are Among Top 7 Mid Cap Stock Gainers Last Week (Sep 8-Sep 14): Are The Others In Your Portfolio?
Do Queasy Side Effects Mean the End of Weight-loss Drug Stock Hype?
Least Shorted S&P 500 Stocks in August
Executive Reshuffles: LLY, S and RY Companies in Focus
Correction: JP Morgan Maintains Overweight on Eli Lilly, Raises Price Target to $1100. Action Price Target Changed to Raises
Piper Sandler Reiterates Overweight on Natera, Maintains $150 Price Target
Natera Analyst Ratings
Citigroup Reinstates Buy on Eli Lilly, Announces $1060 Price Target
Eli Lilly Analyst Ratings
Eli Lilly Wins Buy as Citi Resumes Coverage on Obesity Prospects
US stocks closing | NASDAQ, S&P joined hands for four consecutive positives, US stocks' seven giants all rose, with Meta up nearly 3% and Nvidia up nearly 2%.
In August, the PPI in the United States showed a cooling down of inflation, and the market slightly raised its bets on the Fed's aggressive interest rate cuts. US stocks rose together, with Nvidia up nearly 2%, while NIO Inc and XPeng fell more than 5%. The European Central Bank cut interest rates for the second time this year, but maintained a restrictive policy. European bonds fell, and the euro rebounded from its four-week low. Commodities rose across the board, with US oil briefly rising by 3.7%, gold reaching a new high with a nearly 2% increase, palladium rising by over 4%, and copper experiencing its largest two-month increase.
US stocks closed: Technology breaks through to lift the index, Nasdaq and S&P jointly achieve four consecutive gains.
① After four consecutive days of gains, the S&P 500 index is still 1.3% away from its historical high. ② Warren Buffett's deputy sold more than half of Berkshire Hathaway's positions, causing the stock price to fall for the seventh consecutive day. ③ AirPods Pro transforms into an OTC hearing aid, with FDA approval for Apple's hearing assistance software. ④ Gilead's HIV prevention drug delivers positive results once again.
Looking At Eli Lilly's Recent Unusual Options Activity
Each U.S. State Has at Least 20% of Adults Living With Obesity: CDC
Investing $1.8 billion! Eli Lilly and Co expands its Ireland factory to increase the production of weight loss drugs.
eli lilly's weight loss drug is considered one of the best-selling drugs in history. This time, eli lilly plans to invest $1 billion to expand its existing factory in Limerick, Ireland, and will also invest $0.8 billion to build new facilities at its factory in Kinsale, County Cork, Ireland, to meet the market demand for its star drugs, Mounjaro and Zepbound.
Morgan Stanley Announces Its 15 'Vintage Values' Names of 2025
Eli Lilly and Co. is investing $1.8 billion in Ireland to expand the production capacity of weight loss and Alzheimer's disease drugs.
Eli Lilly and Co will invest $1.8 billion in two manufacturing sites in Ireland to promote the production of its popular weight loss drugs, diabetes medications, and Alzheimer's disease medications.